Compare LMNR & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LMNR | ANIK |
|---|---|---|
| Founded | 1893 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 235.0M | 200.9M |
| IPO Year | 2005 | 1996 |
| Metric | LMNR | ANIK |
|---|---|---|
| Price | $12.78 | $20.74 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $20.00 | $17.00 |
| AVG Volume (30 Days) | ★ 110.1K | 81.2K |
| Earning Date | 06-08-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.37% | N/A |
| EPS Growth | N/A | ★ 80.16 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $159,723,000.00 | $112,819,000.00 |
| Revenue This Year | N/A | $5.98 |
| Revenue Next Year | $13.95 | $7.42 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.67 | $8.67 |
| 52 Week High | $15.43 | $22.88 |
| Indicator | LMNR | ANIK |
|---|---|---|
| Relative Strength Index (RSI) | 38.92 | 51.92 |
| Support Level | $12.56 | $20.13 |
| Resistance Level | $13.79 | $22.70 |
| Average True Range (ATR) | 0.47 | 0.65 |
| MACD | -0.20 | -0.18 |
| Stochastic Oscillator | 17.86 | 42.48 |
Limoneira Co is predominantly an agribusiness company. Its current operations consist of fruit production and marketing, rental operations, real estate, and capital investment activities. The company has three business divisions; agribusiness, rental operations, and real estate development. The agribusiness division which accounts for a majority of the firm's revenue represents its core operations of farming, harvesting, lemon packing, and lemon sales operations. The company's reportable operating segments are fresh lemons, lemon packing, avocados, and other agribusiness, which predominantly includes oranges, specialty citrus, other crops, and farm management services. A majority of its revenue is derived from the Fresh Lemons segment.
Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.